ARTICLE | Company News
Debiopharm, GenOdyssee cancer deal
June 4, 2003 7:00 AM UTC
GenOdyssee (Les Ulis, France) granted an exclusive global license to Debiopharm (Lausanne, Switzerland) to develop and commercialize a GenOdyssee compound. The compound will be selected from a predefi...